chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the afternoon after getting the vaccine she was eating an ice cream bar and had a time trying to eat it, it did not go down and it did not go down.  She ate dinner and at 10:30 she had terrible burning that went through to her back, had shortness of breath like she could not catch her breath.  Her daughter took her to the ER as the pain was so severe she thought she was having a heart attack.  In the ER they ran a bunch of tests, did an EKG and took blood, she did not have a heart attack.  She was admitted and monitored her.  She did have a chest x-ray in the ER as well  Nothing showed blood clots in her lungs, nothing in her lungs, but she still had the SOB and the pain went away.  She thinks they may have given her some medicine and the pain was gone, but she still was shortness and still is today 3/19/21.  She has an appointment next week to have an echocardiogram.  She has had check ups with the cardiologist and her PCP since coming home from the hospital.  Her PCP gave her an inhaler to use but she has not used it.  She did not have any reaction to the injection site itself.  Ever since this has happened has had no appetite, brain fog, shortness of breath, fatigue and nothing sounds good to eat  She can taste okay, but nothing tastes good to her.  She said she doesn't think she can handle this much longer, it's been over a month.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a consumer regarding his 24 month old daughter who experienced an injection site infection, tenderness at the injection site, swelling at the injection site, redness at injection site and irritation at the injection site. At 24 months of age, the patient received the fourth dose on 7/13/2005. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on 7/13/2005. Dose regimen was 1 dose 1 time per day (intramuscular). the patient was not receiving concomitant therapy. On 7/13/2005, the child developed tenderness (injection site pain), swelling (injection site swelling), redness injection site erythema and irritation at the injection site injection site irritation. Two days later the reporter stated that the symptoms were severe and the patient was seen in an ER. She was diagnosed with an injection site infection and was treated with Amoxil. As of 7/26/2005 the tenderness had not resolved.
Staff signed up to get covid vaccine.  Was scheduled and side effects reviewed.  When this writer went into immunization system to enter his injection of Moderna given it was discovered that this staff had already received Pfizer vaccine (both shots) at a different site.  When I asked Kye why he signed up here he stated he didn't know.  Was given more education of covid vaccine and not to get any additional vaccines of others brands as he is already vaccinated.  Client report not feeling any side effects after the Moderna injection.
Some taste lingering in the mouth.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 30Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TASTE DISORDER (non-serious) with onset 30Apr2021, outcome "unknown", described as "Some taste lingering in the mouth".  Additional Information: Reporter is calling about the covid 19 shot. Her and husband got the vaccine about 40 minutes ago. When they drank water they both noticed they have like a fruity taste in the mouth, not fruity but just some taste lingering in the mouth.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This initial spontaneous case, was received from other health professional (nurse) on 06-Nov-2017, concerning a patient of unspecified gender and age. This case refers to 05 out of 18 reports. The patient's medical history and concomitant medications were not reported. It was reported that most of the patients received the vaccine on 09-Oct-17 (as reported), the patient was administered with FLUVIRIN (dose, route of administration, anatomical location, batch number, expiry date: not reported) (explicitly coded to expired vaccine used). It was reported that, the patient had no reaction/had not experienced any adverse event after vaccination. The reporter assessed the events as non-serious.
Severe body aches and pain, chills and shakiness, dizziness, black out / fainting, nausea, stomach pain, vomiting stomach bile, profuse sweating, redness and swelling of injection site, sharp pain in shoulder on injection side, headache, brain fog, fatigue, cough, chest tightness.  Timeline: Shot at 1:15pm. Headache at 6:30pm. Shoulder pain, redness, heat, and swelling on injection site at 8pm. Chills, shaking, body aches at 10pm. Cough, chills, body aches, chest tightness at 10:15pm. Same as above plus increased chest tightness, nausea, and stomach pain at 2am. Sweating, body aches, dizzy, brain fog, fatigue, weakness, stomach pain at 8:30am. Black out / fainting at 2:15pm. Nausea and subsequent vomiting at 2:30pm. Continued body pain, chills, and fatigue for the next 24 hours. All symptoms ended abruptly at 2-3pm next day (48 hours post-injection).
redness in the injection arm when she received the PREVNAR 13 vaccine and was diagnosed with cellulitis; redness in the injection arm/Redness around injection site; redness down her arm/big ring around where it got red and started going down her arm; allergic reaction; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 66-year-old female patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration in left arm on 09Aug2016 in the morning at single dose for immunization. Medical history included penicillin allergy and Sulfa drug allergy from an unknown date and unknown if ongoing. The patient previously had Tetanus shot on 23Apr2015 and Flu shot on unspecified date. The patient's concomitant medications were not reported. The patient experienced redness in the injection arm when she received the PREVNAR 13 vaccine and was diagnosed with cellulitis on 09Aug2016. The patient got a PREVNAR 13 shot back in 09Aug2016 and had a bad reaction. The patient wanted to know if it was the shot or not and wanted to be able to take the COVID shot. The patient has not had any shot since Aug2016. The patient had bad reaction to PREVNAR 13, redness around injection. The patient heard on commercials about redness at injection site. She went to the doctor three times in one week. The redness was growing and ended up with cellulitis in her arm. She wondered if it was the actual PREVNAR 13 shot she was allergic to or if something else happened. The patient was afraid to take the COVID shot because of her reaction with PREVNAR 13. The patient has not taken a Flu shot since then. The patient thought her doctor may have reported it. The patient was wondering if the PREVNAR 13 was actually given in the muscle or maybe bacteria entered at the time of injection. The patient noticed redness down her arm that night on 09Aug2016. The next morning, she noticed it was bigger and went to the doctor's office three times that week. The doctor kept marking it. She was asked if redness got close to her elbow she might need to go to the ER. The patient was prescribed an antibiotic and was allergic to the antibiotic. The patient had a big ring around where it, got red and started going down her arm. The redness continued and was told by her doctor she was having an allergic reaction. The patient was switched to another antibiotic after clindamycin, but doesn't remember which one and then it started working. The facility where the most recent COVID-19 vaccine was administered was in the physician office. No other vaccine was given to the patient on the same date of PREVNAR 13. The patient did not receive any other vaccines within 4 weeks prior. The doctor would just mark the redness on her arm and confirmed that the patient has not yet received the COVID-19 vaccine. The patient was prescribed Clindamycin and redness continued. The answer to the question, if a sample of the product was available to be returned, if requested; and if the packaging was sealed and intact was not provided. The outcome of the events was unknown.
Hives and rash covering about 80% of body. Itching and burning sensation. Raised welts on torso, arms, legs, back. No reaction on face or genitals. Occurred when I woke up on Saturday morning with only hives on arms. It spread throughout the day to cover the entire body. On Sunday body was covered in more hives.  Took benedryl and Claritin starting day 1 of symptoms but it didn?t help. Continued to take. On Sunday evening took Pepcid AC.  Starting to resolve as of Monday morning (now).
pt recv vax 230PM muscle soreness & itching began & became severe by 7PM;area became red & warm to touch;pt visited MD again on 8NOV @ approx 10AM;edema noted @ inj site;pt told to use DPH, ice & advil for pain;
Pt self reported receiving covid vaccines (no vaccine info available). He was admitted on 11/2 and tested positive for covid 11/22
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a 72-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On 12th September 2018, the patient received the 1st dose of SHINGRIX. On 9th November 2018, the patient received the 2nd dose of SHINGRIX. On 13th September 2018, 1 days after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced injection site pain, muscle pain and influenza like illness. On 10th November 2018, the patient experienced injection site pain, muscle pain and influenza like illness. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and itchy rash. On an unknown date, the outcome of the vaccination failure and itchy rash were unknown and the outcome of the shingles was not recovered/not resolved and the outcome of the injection site pain, injection site pain, muscle pain, muscle pain, influenza like illness and influenza like illness were recovered/resolved. It was unknown if the reporter considered the vaccination failure, shingles, injection site pain, muscle pain, influenza like illness and itchy rash to be related to SHINGRIX. It was unknown if the reporter considered the vaccination failure, shingles, injection site pain, muscle pain, influenza like illness and itchy rash to be related to SHINGRIX. Additional details were provided as follows: This case was reported by patient's wife. The patient had his first shot in left arm. The patient experienced a sore arm at the injection site the following day after both shots. The patient also experienced muscle aches like the flu the following day after both shots. The symptoms last a day. Three weeks ago before the date of reporting, a rash developed on his left arm and left side. His doctor said it was a mild case of shingles. The rash also itches. A new area of a few spots just appeared on the date of reporting on the inside of his left elbow. The reporter gave consented to follow up. This case was considered as suspected vaccination failure as time to onset for the event was unknown. This case was linked to the case US2019040249, reported by same reporter.
Severe muscle spasms, severe pain. Severe muscle contractions. Uncontrollable movements of arms and legs. Confusion. Extreme fatigue.  Unable to stay awake. Fever (102) shooting, pain up legs starting in ankles.
Hospitalized 2/28/22-3/3/22 Abd pain, nausea, cough,  O2, SOB, renal mass, urinary retention
Pt recvd 1st dose Hep B vax 12JUN91; that evening pt devel t100-101; also exp joint aches, stiffness, abd pain, fatigue, anorexia, backache, h/a, & faintness; lymph nodes of pts neck became swollen & devel a pruritic rash;
chills; headache; sore arm; This spontaneous case was reported by a  and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (chills) and HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 17-Feb-2021, the patient experienced CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (chills) and HEADACHE (headache) outcome was unknown. Not Provided          No Concomitant information  provided. No Treatment information  provided   This case was linked to MOD-2021-036522 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: TCR: declined follow up. had questions about husband's reactions and had questions.
Flu like symptoms of low grade fever (99.8F), chills, and fatigue.  Slept all day and all night for 24 hours.  Gradually regained strength the next day.
15 days p/vax pt exp severe lower limb myopathy w/extreme pain; inability to walk; bedridden; muscles deteriorated; dx of Graves Disease
Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: Patient reported slight nausea and lightheaded feeling.  We offered water to the patient and had her remain seated.  She stated that she thought she might also be hungry but it began after shot. BP was normal at 124/84.  Patient reported feeling better after sitting for additional time and drinking some water.  Confirmed with patient she felt 100% better prior to leaving the pharmacy and she confirmed- stated she was going to eat as soon as possible in case due to low blood sugar.
same day inc pain/redness @ site-spread w/vasculitic/not cellulitic appearance-gone on day 3;
pt had severe allergic reaction, was given epinephrine, and taken to er by ambulance
This spontaneous report as received from a nurse refers to an unknown number of patients of unknown age and gender. No information on patients medical history or concurrent conditions was provided. From 16-APR-2015 to 30-APR-2015, the patients were vaccinated with improperly stored VAQTA (dose, route, lot # and expiration date were not provided). The reporting nurse stated she had no research the medical records, that is why it was unknown how many patients were involved. The nurse stated no adverse effects were experienced by any patient. This is a one of the several reports from the same reporters source. Additional information has been requested.
foggy head; Chills; Metal smell.; Feeling bad today; Had 031F; This spontaneous case was reported by a pharmacist and describes the occurrence of PAROSMIA (Metal smell.), FEELING ABNORMAL (Feeling bad today), FEELING ABNORMAL (foggy head), PYREXIA (Had 031F) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced PYREXIA (Had 031F). On 05-Jan-2022, the patient experienced PAROSMIA (Metal smell.) and FEELING ABNORMAL (Feeling bad today). On an unknown date, the patient experienced FEELING ABNORMAL (foggy head) and CHILLS (Chills). At the time of the report, PAROSMIA (Metal smell.), FEELING ABNORMAL (Feeling bad today), FEELING ABNORMAL (foggy head), PYREXIA (Had 031F) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported the patient had 031F yesterday (04-Jan-2022).The patient was feeling bad today (05-Jan-2022) metal smell. The patient had chills and foggy head. No concomitant and treatment medications were reported.
Patient had a previous primary series consisting of one Janssen J&J.  Patient agreed to Pfizer Bivalent booster dose.  Nurse accidentally administered a Pfizer Monovalent dose instead of bivalent.  No adverse reactions noted.
Joint pain in fingers, wrists, knees and neck; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 16:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included methemoglobinemia, tennis elbow, tennis elbow, low back pain, depression and anxiety since an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), duloxetine hydrochloride (CYMBALTA), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), rosuvastatin calcium (CRESTOR) and alprazolam (XANAX); all taken for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took prilocaine (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 29Apr2021 at 10:00, the patient experienced joint pain in fingers, wrists, knees and neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event joint pain in fingers, wrists, knees and neck was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt was well on 12/22/99 when the vaccines were given. Experienced an episode of loss of consciousness & limpness on 12/26/99. Seemed lethargic thereafter; watery stools developed. Pt was hospitalized and had no further episodes.
approx 20 hrs following vax t106R taken to hosp @ office temp 102 R noticed twitching in late afternoon p/leaving PMD office & called mom; pt was taken to ER; dx febrile sz from moms description recommended DT in future
Heavy menstration every month since COVID vaccine. Severity is comparable to teenage years periods (severe cramps and heavy flow).  Period also came earlier (twice within 3 weeks).
10/9/2006: (3 DAYS POST INJECTION) DEVELOPED RED RASH, SWELLING OF FACE, EYES, LIPS, WITH COUGHING. 10/10/2006 TREATED IN PHYSICIAN OFFICE GIVEN TUSSIONEX FOR COUGH LAB DRAWN 10/11/2006: BECAME INCREASINGLY WORSE WENT TO THE EMERGENCY ROOM TREATED WITH EPI 1:1000 0.3ML, SOLUMEDROL 125 MGM IV, BENADRYL 50 MGM IV, PEPCID 20 MGM IV, SINGULAIR 10 MGM PO, ALBUTEROL UPDRAFT TIMES TWO. DISCHARGED WITH PRESCRIPTION FOR SINGULAIR 10 MGM DAILY, BENADRYL 50 MGM BY MOUTH EVERY 6 HOURS TIMES 4 DOSES, PREDNISONE 40 MGM X DAYS 1 & 2, 30MGM TIMES DYS 3 & 4, 20 MGM TIMES DAYS 5 & 6 AND 10 MGM DAYS 7& 8.  10/13/06: REFERRED TO A DERMATOLOGIST FOR EVALUATION.
HIVES ON BACK AND ARM; BODY ACHED UNDERARM; CHILLS; TIRED; This spontaneous report received from a patient concerned a 60 year old of unspecified sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced tired. On 02-APR-2021, the subject experienced chills. On 03-APR-2021, the subject experienced body ached underarm. On 07-APR-2021, the subject experienced hives on back and arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ached underarm on 05-APR-2021, chills on 03-APR-2021, and tired on 04-APR-2021, and was recovering from hives on back and arm. This report was non-serious.
Pt fainted after vaccine, anxious. Pt's mother reported gradual loss of peripheral vision on right side. Confirmed by ophthalmology since decreased vision on right started 8/23/05.
chills; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient wife).     A 64-years-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 05Mar2021 05:30 as DOSE 1, SINGLE for covid-19 immunisation (age at vaccination 64 years). The patient medical history and concomitant medications were not reported. The patient experienced chills and fever on an unspecified date, after the first dose of vaccination. The patient later received second dose of received bnt162b2 (BNT162B2, solution for injection, Lot number: EN6203), via an unspecified route of administration, administered in Arm Left on 26Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient arrived in clinic to receive their first dose of COVID 19  vaccine. Lower than authorized dose administered.  Administered 10 mcg/0.2mL, NDC: 80777-0283-02 to 7 month old child.  Information provided by the CDC & local source relating to the updated COVID 19 vaccination schedules on 04/18/2023 was not clear.  Specificity of vaccine dose & injection volume in disseminated informations from these sources would have improved our understading. This error was discovered  weeks following it's occurence.
This spontaneous report as received from an unspecified healthcare professional, as part of a marketing research program "ZSOTAVAX specialty insights research (reference # RH-12-5437)", refers to a patient of unknown age with no concomitant therapy and no relevant medical history. On an unknown date the patient was vaccinated with ZOSTAVAX (dose and lot # unknown). About a year ago on an unknown date in December 2012 the patient experienced non efficacy and patient mentioned developed shingles after being vaccinated. The outcome of adverse events was unknown. The reporter considered the events to be not related with the vaccination. Additional information is not expected.
Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pulmonary arterial hypertension. Concomitant products included TREPROSTINIL SODIUM (REMODULIN) from 02-Feb-2021 to an unknown date for an unknown indication.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact